# Cardiovascular Protection After Preeclampsia With Enalapril

> **NCT07222852** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Women and Infants Hospital of Rhode Island** · enrollment: 60 (estimated)

## Conditions studied

- Preeclampsia
- Hypertensive Disorder of Pregnancy
- Hypertension
- Gestational Hypertension
- Gestational Hypertension After Childbirth

## Interventions

- **DRUG:** Enalapril
- **OTHER:** Standard treatment

## Key facts

- **NCT ID:** NCT07222852
- **Lead sponsor:** Women and Infants Hospital of Rhode Island
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-11-15
- **Primary completion:** 2027-10-15
- **Final completion:** 2027-10-15
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07222852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07222852, "Cardiovascular Protection After Preeclampsia With Enalapril". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07222852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*